FDA’s Promotional Assessments Reorganized Around Specialty, Not Target Audience

The two divisions within the Office of Prescription Drug Promotion are renamed the divisions of advertising and promotion review I and II; they will each have four teams operating within them in a structure akin to the Office of New Drugs.